Francesco Multinu

review 2021

Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes

Gynecologic Oncology ·doi:10.1016/j.ygyno.2021.06.033

Clear cell carcinoma of the ovary is a rare and distinct histotype of epithelial ovarian carcinomas. Women diagnosed with clear cell carcinomas are usually younger and diagnosed at earlier stages than those with the most common high-grade s…

observational 2021

Surgical morbidity of total laparoscopic hysterectomy for benign disease: Predictors of major postoperative complications

European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2021.06.023

OBJECTIVE: To estimate rate of perioperative complications and to define risk factors of 30-day major (Clavien-Dindo ≥ 2) postoperative complications of total laparoscopic hysterectomy (TLH) for benign disease. STUDY DESIGN: An uncontrolle…

observational 2018

Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation

JAMA surgery ·doi:10.1001/jamasurg.2018.0141

IMPORTANCE: In November 2014, the US Food and Drug Administration (FDA) issued a black box warning against the use of power morcellation for excision of uterine fibroids to decrease the risk of disseminating malignant cells and worsening su…

meta-analysis 2015

Progestins for Symptomatic Endometriosis: Results of Clinical Studies

·doi:10.2174/157488551002151222160051

Progestins, which are synthetic progestational compounds, have been used in the management of symptomatic endometriosis, both as primary therapy and as an adjunct to surgery. Several oral compounds have been used for this purpose, and diffe…